Rocket Pharmaceuticals, Inc. (RCKT) Operating cash flow 2016–2025
Rocket Pharmaceuticals, Inc. (RCKT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$190.0MFY2025 · since FY2016: -$5.5M → -$190.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$190.0M | +9.4% |
| FY2024 | -$209.7M | -7.6% |
| FY2023 | -$194.9M | -9.4% |
| FY2022 | -$178.1M | -47.0% |
| FY2021 | -$121.2M | -62.3% |
| FY2020 | -$74.6M | -15.4% |
| FY2019 | -$64.7M | -20.2% |
| FY2018 | -$53.8M | -237.0% |
| FY2017 | -$16.0M | -190.1% |
| FY2016 | -$5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RCKT financial trends
RCKT RevenueRCKT Net incomeRCKT Net marginRCKT Gross profitRCKT Gross marginRCKT Operating incomeRCKT Operating marginRCKT Free cash flowRCKT Capital expendituresRCKT Return on equityRCKT Stock buybacksRCKT Dividends paidRCKT Total assetsRCKT Total liabilitiesRCKT Shareholders’ equityRCKT overview →